|Videos|April 20, 2022
The Top 3 Technological Challenges in Decentralized Trials
Author(s)IQVIA
Nagaraja Srivatsan, SVP & Chief Digital Officer at IQVIA, breaks down the most recent challenges in the decentralized trial space: patient burden, the ecosystem between the patient and information, and the global regulatory landscape.
- The harmony of decentralized trials is when site, sponsor, and patient come together.
- There is no one size fits all for technological adaptations when it comes to the patient.
- Regulations for data flow, GDPR, patient privacy, and more are constantly coming in, and must be adhered to.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
Accelerate Inclusive Enrollment and Delivery with LightshipFebruary 19th 2025
Harmonizing Data in Clinical ResearchOctober 21st 2024
Parexel’s FSP: Evolving With Your Needs Now and in the FutureOctober 3rd 2024
Trending on Applied Clinical Trials Online
1
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
2
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
3
Generative AI Transforms Clinical Study Report Development
4
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
